摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

methyl (6S)-6-hydroxy-8-trimethylsilyl-oct-7-ynoate | 1041860-95-0

中文名称
——
中文别名
——
英文名称
methyl (6S)-6-hydroxy-8-trimethylsilyl-oct-7-ynoate
英文别名
methyl (6S)-6-hydroxy-8-trimethylsilyloct-7-ynoate
methyl (6S)-6-hydroxy-8-trimethylsilyl-oct-7-ynoate化学式
CAS
1041860-95-0
化学式
C12H22O3Si
mdl
——
分子量
242.39
InChiKey
MQBAPMZFPLPZDF-NSHDSACASA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.96
  • 重原子数:
    16.0
  • 可旋转键数:
    5.0
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.75
  • 拓扑面积:
    46.53
  • 氢给体数:
    1.0
  • 氢受体数:
    3.0

反应信息

  • 作为反应物:
    描述:
    methyl (6S)-6-hydroxy-8-trimethylsilyl-oct-7-ynoate咪唑 、 potassium fluoride 、 Schwartz's reagent 、 三乙胺 作用下, 以 二氯甲烷N,N-二甲基甲酰胺 为溶剂, 反应 24.5h, 生成 methyl (E,6S)-6-[tert-butyl(dimethyl)silyl]oxy-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)oct-7-enoate
    参考文献:
    名称:
    [EN] REVERSIBLE MACROCYCLIC KINASE INHIBITORS
    [FR] INHIBITEURS DE KINASE RÉVERSIBLES MACROCYCLIQUES
    摘要:
    The present invention relates to macrocyclic compounds and compositions containing said compounds acting as kinase inhibitors. Moreover, the present invention provides processes for the preparation of the disclosed compounds, as well as methods of using them, for instance as a medicament, in particular for the treatment specific kinase mediated disorders, such as cancer.
    公开号:
    WO2023110936A1
  • 作为产物:
    描述:
    二(三甲基甲硅烷基)乙炔 在 aluminum (III) chloride 、 [RhCl2(p-cymene)]2 、 (1S,2S)-(+)-N-对甲苯磺酰基-1,2-二苯基乙二胺 、 potassium hydroxide 作用下, 以 二氯甲烷异丙醇 为溶剂, 反应 2.0h, 生成 methyl (6S)-6-hydroxy-8-trimethylsilyl-oct-7-ynoate
    参考文献:
    名称:
    [EN] REVERSIBLE MACROCYCLIC KINASE INHIBITORS
    [FR] INHIBITEURS DE KINASE RÉVERSIBLES MACROCYCLIQUES
    摘要:
    The present invention relates to macrocyclic compounds and compositions containing said compounds acting as kinase inhibitors. Moreover, the present invention provides processes for the preparation of the disclosed compounds, as well as methods of using them, for instance as a medicament, in particular for the treatment specific kinase mediated disorders, such as cancer.
    公开号:
    WO2023110936A1
点击查看最新优质反应信息

文献信息

  • Highly Stereoselective and Modular Syntheses of 10-Hydroxytrilobacin and Three Diastereomers via Stereodivergent [3 + 2]-Annulation Reactions
    作者:Chan Woo Huh、William R. Roush
    DOI:10.1021/ol801242d
    日期:2008.8.7
    convergent synthesis of the annonaceous acetogenin, 10-hydroxytrilobacin ( 4a), was accomplished by using the [3 + 2]-annulation reaction of tetrahydrofuranyl carboxaldehyde 2a and allylsilane 3. The stereodivergency of the [3 + 2]-annulation reaction made it possible to achieve modular, highly stereoselective syntheses of three 10-hydroxytrilobacin diastereomers from the same precursors by using simple
    通过使用四氢呋喃甲醛2a和烯丙基硅烷3的[3 + 2]环合反应,可以完成壬基产乙酸原素10-羟基三叶草素(4a)的聚合反应。通过简单地改变反应条件,就可以从相同的前体中获得模块化的,高度立体选择性的三种10-羟基三叶球蛋白非对映异构体的合成方法。
查看更多